WILMINGTON, N.C.--(BUSINESS WIRE)--PPD, Inc. (Nasdaq: PPDI) today announced it has established four practice areas through PPD® Consulting—biosimilars, adaptive trial design, China regulatory strategy and cardiovascular outcomes studies—strengthening the company’s ability to help clients meet unique product development challenges across multiple disciplines.
